"Mitotic Index" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An expression of the number of mitoses found in a stated number of cells.
| Descriptor ID |
D008940
|
| MeSH Number(s) |
E01.370.225.500.385.500 E05.200.500.385.500 E05.242.385.500
|
| Concept/Terms |
Mitotic Index- Mitotic Index
- Index, Mitotic
- Indices, Mitotic
- Mitotic Indices
|
Below are MeSH descriptors whose meaning is more general than "Mitotic Index".
Below are MeSH descriptors whose meaning is more specific than "Mitotic Index".
This graph shows the total number of publications written about "Mitotic Index" by people in this website by year, and whether "Mitotic Index" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mitotic Index" by people in Profiles.
-
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance). J Clin Oncol. 2017 Apr 01; 35(10):1061-1069.
-
Phosphohistone H3: implications for clinical practice and risk assessment in meningioma. Neuro Oncol. 2015 May; 17(5):631-3.
-
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathol. 2015 Apr; 129(4):585-96.
-
Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma. Brain Pathol. 2015 May; 25(3):266-75.
-
Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther. 2006 Aug; 5(8):2023-33.
-
Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res Treat. 2005 May; 91(1):47-60.
-
Evidence for an ontogenetic basis for circadian coordination of cancer cell proliferation. J Natl Cancer Inst. 1998 Oct 07; 90(19):1480-4.
-
Inhibition of insulin like growth factor II autocrine growth of Wilms' tumor by suramin in vitro and in vivo. Cancer Lett. 1996 May 15; 103(1):49-56.
-
Automatic quantitation of cell growth and determination of mitotic index using DAPI nuclear staining. Pediatr Pathol. 1993 Mar-Apr; 13(2):249-65.
-
Relationship of glutathione depletion and inhibition of glutathione-S-transferase activity to the antimitotic properties of estramustine. Cancer Treat Rep. 1986 Jun; 70(6):715-20.